Creative Medical Technology Holdings, Inc. (CELZ) Operating Margin
- Operating margin · 12 months: Value -208004.40%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -208004.40% | Operating income / revenue. Period ending 2026-06-30. $-6.24M ÷ $3.00K × 100 ≈ -208004.40% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -6.24M USD | Operating Income (Loss) |
| Revenue | 3.00K USD | |
| Cost of products and services | (m) | |
| Research and development | 2.02M USD | Research and Development Expense |
| Selling, general and administration | 4.11M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-6.24M | $3.00K | (m) | $2.02M | $4.11M | -208004.40% |
| 2026-03-31 | $-5.94M | $3.00K | (m) | $2.06M | $3.76M | -198049.63% |
| 2025-12-31 | $-6.14M | $6.00K | (m) | $2.26M | $3.76M | -102380.23% |
| 2025-09-30 | $-6.08M | $6.00K | (m) | $2.18M | $3.79M | -101379.43% |
| 2025-06-30 | $-5.92M | $6.00K | (m) | $2.30M | $3.51M | -98656.77% |
| 2025-03-31 | $-6.28M | $14.00K | (m) | $2.72M | $3.46M | -44865.66% |
| 2024-12-31 | $-5.74M | $11.00K | (m) | $2.40M | $3.24M | -52216.92% |
| 2024-09-30 | $-5.63M | $11.00K | (m) | $2.28M | $3.24M | -51181.51% |
| 2024-06-30 | $-6.06M | $17.00K | (m) | $2.69M | $3.28M | -35667.51% |
| 2024-03-31 | $-5.63M | $9.00K | (m) | $2.07M | $3.46M | -62557.88% |
| 2023-12-31 | $-5.62M | $9.00K | (m) | $1.97M | $3.56M | -62445.91% |
| 2023-09-30 | $-10.13M | $24.60K | (m) | $6.99M | $3.06M | -41163.54% |
| 2023-06-30 | $-9.60M | $73.60K | (m) | $6.23M | $3.34M | -13048.19% |
| 2023-03-31 | $-10.20M | $73.60K | (m) | $6.58M | $3.58M | -13862.19% |
| 2022-12-31 | $-10.24M | $88.60K | (m) | $6.27M | $3.94M | -11562.50% |
| 2022-09-30 | $-5.44M | $137.75K | (m) | $950.63K | $4.47M | -3948.46% |
| 2022-06-30 | $-5.25M | $92.75K | (m) | $778.88K | $4.42M | -5662.48% |
| 2022-03-31 | $-3.98M | $102.75K | (m) | $119.18K | $3.81M | -3870.29% |
| 2021-12-31 | $-3.13M | $87.75K | (m) | $109.18K | $2.96M | -3562.17% |
| 2021-09-30 | $-1.98M | $37.50K | (m) | $59.18K | $1.85M | -5270.10% |
| 2021-06-30 | $-1.39M | $104.50K | (m) | (m) | $1.38M | -1325.67% |
| 2021-03-31 | $-1.08M | $122.40K | (m) | (m) | $1.10M | -885.41% |
| 2020-12-31 | $-1.11M | $164.50K | (m) | $0.00 | $1.16M | -677.71% |
| 2020-09-30 | $-1.12M | $142.60K | (m) | (m) | $1.16M | -787.07% |
| 2020-06-30 | $-1.15M | $123.10K | (m) | (m) | $1.19M | -936.89% |
| 2020-03-31 | $-1.21M | $156.80K | (m) | (m) | $1.29M | -774.56% |
| 2019-12-31 | $-1.13M | $165.50K | (m) | $0.00 | $1.22M | -682.88% |
| 2019-09-30 | $-1.12M | $227.50K | (m) | $86.34K | (m) | -492.27% |
| 2019-06-30 | $-1.12M | $222.40K | (m) | $89.22K | (m) | -504.20% |
| 2019-03-31 | $-1.16M | $165.60K | (m) | $93.42K | (m) | -700.91% |
| 2018-12-31 | $-1.11M | $124.40K | (m) | $96.62K | (m) | -895.68% |
| 2018-09-30 | $-1.04M | $71.60K | (m) | $97.62K | (m) | -1452.31% |
| 2018-06-30 | $-1.06M | $19.20K | (m) | $182.47K | (m) | -5520.91% |
| 2018-03-31 | $-1.14M | $14.40K | (m) | $203.45K | (m) | -7924.83% |
| 2017-12-31 | $-1.18M | $4.80K | (m) | $260.08K | (m) | -24537.63% |
| 2017-09-30 | $-1.13M | $0.00 | (m) | $190.52K | (m) | (m) |
| 2017-06-30 | $-1.54M | $0.00 | (m) | $147.96K | (m) | (m) |
| 2017-03-31 | $-861.58K | $0.00 | (m) | $140.80K | (m) | (m) |
| 2016-12-31 | $-766.07K | $0.00 | (m) | $85.33K | (m) | (m) |
| 2016-09-30 | $-577.95K | $0.00 | (m) | (m) | (m) | (m) |
| 2016-06-30 | $-367.17K | $0.00 | (m) | (m) | (m) | (m) |
| 2016-03-31 | $-16.36K | $0.00 | (m) | (m) | (m) | (m) |
| 2015-12-31 | $-20.83K | $0.00 | (m) | (m) | (m) | (m) |
| 2015-09-30 | $-18.69K | $0.00 | (m) | (m) | (m) | (m) |
| 2015-06-30 | $-18.51K | $0.00 | (m) | (m) | (m) | (m) |
| 2015-03-31 | $-18.38K | $0.00 | (m) | (m) | (m) | (m) |
| 2014-12-31 | $-19.43K | $0.00 | (m) | (m) | (m) | (m) |
| 2014-09-30 | $-19.31K | $0.00 | (m) | (m) | (m) | (m) |
| 2014-06-30 | $-19.35K | $0.00 | (m) | (m) | (m) | (m) |
| 2014-03-31 | $-19.70K | $0.00 | (m) | (m) | (m) | (m) |
| 2013-12-31 | $-20.12K | $0.00 | (m) | (m) | (m) | (m) |
| 2013-09-30 | $-20.54K | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | $-21.03K | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | $-20.74K | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $-20.10K | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | $-21.20K | $0.00 | (m) | (m) | (m) | (m) |
| 2012-06-30 | $-20.62K | $0.00 | (m) | (m) | (m) | (m) |
| 2012-03-31 | $-20.37K | $0.00 | (m) | (m) | (m) | (m) |
| 2011-12-31 | $-19.83K | $0.00 | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $-14.29K | $0.00 | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |